Grenoble Alps University
Also known as: Centre hospitalier universitaire grenoble alpes | CHU de Grenoble | CHU de Grenoble - La Tronche - Hôpital A. Michallon, France | CHU Grenoble Alpes | CHU Grenoble Alpes, Grenoble Alpes University | Clinical pharmacology unit, grenoble alpes university hospital | EFCR Department and Sleep Laboratory, Grenoble Alpes University Hospital | Grenoble Alpes University Hospital | Grenoble Alpes University Hospital (CHUGA) | Grenoble - CHU | Grenoble University Hospital, Clinical Pharmacology Department | IDEX - Univ. Grenoble-Alpes | Laboratoire SENS, Univ. Grenoble-Alpes | Métropole Grenoble-Alpes | UniversitéGrenobleAlpes | Université Grenoble Alpes | Université Grenoble-Alpes | Université Grenoble Alpes, LIP/PC2S, EA 4145, Grenoble
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2013Last known activity
Apr 30, 2022
Timeline
1330s
- Jan 1, 1339
Grenoble Alps University— Founded
Drugs by trial phase (12 distinct, 11 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Atherosclerosis
- Carcinoma, Non-Small-Cell Lung
- Cardiovascular Diseases
- Coronary Artery Disease
- Diabetic Foot
- Foot Ulcer
- Hemorrhage
- Ischemia
- Lung Neoplasms
- Myelodysplastic Syndromes
- Myocardial Ischemia
- Preleukemia
- Prostatic Neoplasms
- Scleroderma, Diffuse
- Scleroderma, Systemic
- Shock, Hemorrhagic
- Skin Ulcer
- Syndrome
- Ulcer
Recent trials (12)
- NCT05235685Overall official - principal investigatorN/AApr 30, 2022
- NCT05235685Study chairN/AApr 30, 2022
- NCT04621188Study chairPhase 2Jan 31, 2021
- NCT04483167Overall official - principal investigatorPhase 1Sep 15, 2020
- NCT04338165Overall official - principal investigatorPhase 2Jun 30, 2020
- NCT04111705Study chairPhase 2Oct 31, 2019
- NCT03749577Overall official - principal investigatorN/AOct 1, 2019
- NCT03654989Overall official - principal investigatorPhase 1/Phase 2Sep 1, 2018
- NCT03488810Overall official - principal investigatorPhase 3Aug 1, 2018
- NCT03218722Overall official - principal investigatorPhase 3Dec 29, 2017
- NCT03120533CollaboratorPhase 1/Phase 2Apr 1, 2017
- NCT03598582Overall official - principal investigatorPhase 4Jan 1, 2013
Details
- Founded
- Grenoble, FR Jan 1, 1339
- Last known activity
- Apr 30, 2022